Discover Magazine (blog)Update on the Journal of Stem CellsDiscover Magazine (blog)The ethics of some of the human stem-cell studies published in the Journal was also a major concern. One paper reported a trial of an surgical treatment for children wit… Continue reading
BioTechniques.com |
PLANTS IN THE CRISPR
BioTechniques.com From gene-edited human embryos to disease-free pigs for donor organs, applications of CRISPR/Cas9 technology are filling the headlines. But the impact of this gene-editing technique isn’t limited to biomedical research: Plant biologists are also using … |
BSI bureau (press release) |
India and Japan join hands for stem cell research
BSI bureau (press release) In the light of Japan’s Prime Minister Shinzo Abe’s visit to India, the two countries have signed a host of agreements to further cooperation in science and technology, including research into stem–cells for making bone-marrow transplants more accessible. |
Labiotech.eu (blog) |
Inside the Lab Building a Stem Cell Gun to Heal Skin
Labiotech.eu (blog) Thomas Bold, CEO of RenovaCare, shares the story of how his team developed a futuristic stem cell gun to heal burns and wounds. Inside the building that used to be home to Berlin’s Tempelhof airport, whose abandoned runways are regularly visited by … |
The Hindu |
Hyderabad techie donates stem cells to save 7-year-old boy
Times of India VIJAYAWADA: Chaitanya, a 32-year old young IT professional from Hyderabad, saved the life of a 7-year-old, Sarvesh, by donating his blood stem cells. “I was very happy to hear that my stem cells were a potential match for someone.The fact that my … When new life stems from an altruistic donationThe Hindu Boy cured of thalassaemia meets saviourThe New Indian Express AIIMS with 50 students from next academic year, says KamineniThe Hans India |
|
Oxford BioMedica plc New era for cell and gene therapies
DirectorsTalk Interviews Advanced therapies: In only a week, gene therapies and gene-modified cell therapies have entered the global limelight: the first approval of a CAR-T therapy; Gilead’s $12bn acquisition of US CAR-T biotech Kite Pharma; and the UK government’s … |